 |  |  |  | |
 |  |  |  |
 |
 |
 |  |  |  |  |  |  |  |  |  |  |  |  |  |
 |
Aims and Scope
Clinical Approaches in Bipolar Disorders is an international, peer-reviewed journal. Its aim is to enhance communication and discussion of the key issues affecting those active in the diagnosis, treatment, and overall care of patients with bipolar disorders, including psychiatrists, psychiatric nurses, and primary care physicians. Through independent expert selection of topics and peer review, the journal seeks to inform, educate, and unify these individuals, globally, towards a greater appreciation and understanding of bipolar disorders and patients’ needs to improve the quality of treatment and care provided.
Uniquely for a journal in this field, Clinical Approaches in Bipolar Disorders includes a designated CME-accredited section in selected issues, enabling it to fulfil an important role in medical education. Only articles with robust educational content will be considered for accreditation. Each educational activity will be designated with a maximum of 1 hour in Category 1 credit towards the AMA Physician’s Recognition Award. Only those hours actually spent in the educational activity should be claimed.
Uniquely for a journal in this field, Clinical Approaches in Bipolar Disorders includes a designated CME-accredited section in selected issues, enabling it to fulfil an important role in medical education. Only articles with robust educational content will be considered for accreditation. Each educational activity will be designated with a maximum of 1 hour in Category 1 credit towards the AMA Physician’s Recognition Award (PRA). Only those hours actually spent in the educational activity should be claimed. The American Medical Association has determined that physicians not licensed in the United States, who participate in this CME activity are eligible for AMA PRA Category 1 credit.
Articles may be provocative and challenging, but this should not be at the expense of scientific accuracy. All articles will be subject to peer review by at least two independent experts. Authors are invited to suggest up to five potential independent peer reviewers. Use of these reviewers is at the discretion of the Editors-in-Chief; alternatively, they may make their own selections. Following peer review, the manuscript will be returned to the lead author for revision. Authors will be kept informed of their article throughout the publication process.
Clinical Approaches in Bipolar Disorders is distributed throughout the world to universities, medical schools, medical libraries, research institutes, hospitals, and individual subscribers. The journal is supported by an unrestricted educational grant from AstraZeneca. This enables the publisher, Cambridge Medical Publications, to provide the journal free of charge to a certain number of individuals determined at its discretion and allocated on a ‘first come, first served’ basis. You are invited to subscribe to receive Clinical Approaches in Bipolar Disorders in print. Articles printed in this publication are at the invitation of the Editors-in-Chief and the Editorial Board. If you have an idea for an article, please contact the Publishing Editor, who will liaise with the Editors-in-Chief concerning your suggestion. All manuscripts submitted for publication are peer reviewed, and the main criterion is that all articles have a predominantly clinical focus.
Although great care is taken to ensure accuracy, Cambridge Medical Publications cannot be liable for any errors or inaccuracies in this publication. Opinions expressed are those of the authors. Cambridge Medical Publications, the Editors-in-Chief, the Editorial Board, and the grantor cannot be held responsible for the validity of clinical treatments, dose regimens or other medical statements. All dosages referred to in articles should be checked against the relevant data sheet for the product.
Clinical Approaches in Bipolar Disorders is published by Cambridge Medical Publications with the support of an unrestricted educational grant from AstraZeneca. The terms of the grant are such that AstraZeneca has no influence over the contents of the journal and can make no restriction or other decision regarding distribution. The Editors-in-Chief and Editorial Board remain free to determine content, and accept or reject articles in accordance with standard journal practice. The publisher, Cambridge Medical Publications, is free to take all decisions regarding distribution and subscriptions. The educational grant is made to further the global understanding of bipolar disorder, inform, and educate practising physicians in this field with a view, ultimately, to improving patient care.
|
